Poland· PL-100160806

Zibor

A bemiparin product containing bemiparinum natricum, registered in Poland by GINELADIUS S.L. The same ATC class is registered in 4 of our 19 countries.

ATC B01AB12

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedZiborATCB01AB12REGISTER NO.PL-100160806PACKS LISTED4CHECKEDSeptember 27, 2026

Where it is registered

Bemiparin is registered in 4 of 19 countries.

Countries holding a registration under ATC B01AB12 (bemiparin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 2 of them publish a price we can compare per daily dose

Bemiparin · ATC B01AB12

4 / 19 countries

  • Czechiaprice
  • Ireland
  • Polandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Bemiparinum natricum
Manufacturer
GINELADIUS S.L
Country
Poland (PL)
ATC code
B01AB12
ATC class
Bemiparin
Defined daily dose
2.5 TSD, E
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 4

  • gtin
    05909990586684
  • gtin
    05909990586691
  • gtin
    05909990586714
  • gtin
    05909990586721

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Bemiparin in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bemiparin products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/20c5423c-c364-4959-81e7-429cd32e8e50
GET /v1/drugs/20c5423c-c364-4959-81e7-429cd32e8e50?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Roztwór do wstrzykiwań w ampułko-strzykawce",
  "source": "urpl",
  "strength": "3500 j.m. anty Xa/0,2 ml",
  "packaging": "05909990586684 ¦ Rp ¦ 32801\n2 amp.-strzyk. 0,2 ml\n05909990586691 ¦ Rp ¦ 32802\n10 amp.-strzyk. 0,2 ml\n05909990586714 ¦ Rp ¦ 32804\n30 amp.-strzyk. 0,2 ml\n05909990586721 ¦ Rp ¦ 32805\n100 amp.-strzyk. 0,2 ml",
  "substance": "Bemiparinum natricum 3500 j.m. anty Xa/0.2 ml",
  "common_name": "Bemiparinum natricum",
  "pl_product_id": "100160806",
  "pozwolenie_nr": "12200",
  "auth_procedure": "MRP",
  "authorisation_validity": "Bezterminowe"
}

See everything about bemiparin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.